Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Pfizer Inc N.PFE


Primary Symbol: PFE

Healthcare
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Opinion & Analysis (NYSE:PFE)

BioNTech, Eastman Kodak, EXMceuticals - investors have the chance to profit

Mario Hose July 29, 2020

BioNTech, Evotec, EXMceuticals - which stocks have the potential to double?

Mario Hose June 18, 2020

Buzz on the Bullboards: HOT Coronavirus Healthcare Stocks

Omri Wallach March 19, 2020

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

Streetwise Reports July 31, 2019

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Streetwise Reports July 9, 2019

The ProMIS of an Alzheimer's cure

The Life Sciences Report May 4, 2017

Drug pricing, presidential politics, and three biotechs with promise

The Life Sciences Report April 13, 2016

From acorns mighty trees can grow: Laidlaw's Jim Molloy on budding small-cap biotechs

The Life Sciences Report March 16, 2016

Circling the globe for uncommon biotech opportunities

The Life Sciences Report February 18, 2016

Healthcare Humbled, But Not Knocked Out

Benzinga.com  October 10, 2015

BTIG's Hartaj Singh's advice for biotech investors: 'hold your powder' 'til winter

Gail Dutton October 1, 2015

Keep The Quality And The Large Caps With This New ETF

Benzinga.com  September 24, 2015

Bearish On Bucks? Try This ETF

Benzinga.com  September 18, 2015

Buy biotech when there's blood on the street: Pontifax's Ran Nussbaum

George S. Mack September 3, 2015

ETFs For The Next Pharma Takeover Candidates

Benzinga.com  July 28, 2015

Probe biotech's diverse subsectors for strong, undervalued companies: Van Leeuwenhoeck's Marcel Wijma

Gail Dutton July 2, 2015

Opportunities in cancer immunotherapy throttle up: George Zavoico of JonesTrading

George S. Mack June 25, 2015

Healthcare, Yen And Oil ETFs To Watch This Week

Benzinga.com  May 31, 2015

U.S. Tech, Dollar & Health Care ETFs To Watch This Week

Benzinga.com  April 26, 2015

Sector ETFs And Earnings

Benzinga.com  April 7, 2015